Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Attendees will have the opportunity to hear the results of cutting edge studies and to learn about the new ESC Clinical Practice Guidelines on Cardiac Pacing and Cardiac Resynchronisation, which are likely to have a tremendous impact on the European health care system.
Sophia Antipolis, 16 May 2013: A packed programme is promised for EHRA EUROPACE 2013 meeting, taking place in Athens, Greece, 23 to 26 June, with the results of ten late breaking clinical trials and over 1000 original abstracts featured, offering exciting opportunities for news stories. The biennial meeting, which for the first time represents a collaboration between the European Heart Rhythm Association (EHRA) of the ESC and the ESC Working Groups on Cardiac Cellular Electrophysiology and e-Cardiology, promises to be more wide ranging than ever before. An eagerly anticipated news event will be the launch of the 2013 ESC Clinical Practice Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy.EHRA Scientific Programme Committee chairperson Professor Andreas Goette, said:
“This is the first time we’ve ever featured late breaking trials. Journalists will have the opportunity to hear the results of really cutting edge studies, and to learn about the new Guidelines which are likely to have a tremendous impact on the European health care system.”
The new partnership between EHRA and the Working groups on Cardiac Cellular Electrophysiology and e Cardiology, he added, emphasized the multidisciplinary and translational approach currently taking place in the diagnosis and therapy of arrhythmias and conduction disturbance.
“Our programme now encompasses the entire breadth of arrhythmogenesis, from cell to bedside,” he said.
The meeting, which spans four days, features over 110 individual sessions, and 18 satellite symposia, is likely to be attended by around 6,000 clinical electro physiologists, general cardiologists, family doctors, basic scientists, computer specialists, cath lab technicians and nurses. Highlights of the late breaking clinical trials, to be presented on Tuesday 25 June and Wednesday 26 June include:
Altogether, a record breaking 1084 abstracts have been accepted (out of a total of 1624 submissions) to be presented at the EHRA EUROPACE 2013. In addition to oral abstract sessions and moderated poster sessions, new for this year will be ‘flash’ abstract presentations where related abstract topics are grouped together.
“The idea here is to provide the audience with a lot of information on specific topics, like cardiac resynchronisation therapy or implantable cardioverter defibrillators, in a really short space of time. It should enable delegates to get up to speed on the latest developments quickly,” explained Goette.
Interesting abstracts to watch out for include:
Undoubtedly a major news event will be the launch of the ESC Clinical Practice Guidelines on Cardiac Pacing & CRT which will be presented at EHRA EUROPACE 2013 on Tuesday 25 June. Professor Michele Brignole, chairman of the Guideline Task Force, said,
“These Guidelines, which have been mediated by a team of 70 experts, represent the synthesis of the latest knowledge and state of the art in cardiac pacing and cardiac resynchronisation therapy. They should help place all the studies that have been published over the last six years in context.”
Sessions that might form the basis for topical features include: remote monitoring of patients with ICDs; what electrophysiologists need to know about renal denervation; new technologies in the treatment of complex arrhythmias; new types of antiarrhythmic drugs for atrial fibrillation and the home monitoring of cardiac devices. Two summits, where related sessions on lead management and the cardiogenetics of arrhythmias are being brought together, will also be featured.
“The idea here is that delegates can spend the day immersing themselves in these areas and getting completely updated,” explained Goette.
Other key events will include an update on the ICD for Life initiative, looking to boost prophylactic implantation of ICD’s in Eastern Europe, and an update of 10 years of the German Atrial Fibrillation Network (AFNET). In fact EHRA EUROPACE2013 promises to be a meeting of anniversaries, with EHRA celebrating its 10th Anniversary of becoming an ESC association.ENDS
Scientific Programme Online
About EHRA EUROPACEEHRA EUROPACE is an established, international conference attracting key opinion leaders, well-recognised scientists, physicians, allied professionals and industry, A record-breaking 5560 participants attended our last meeting.About EHRAThe European Society of Cardiology (ESC) represents more than 80 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.The European Heart Rhythm Association (EHRA) is a registered branch of the ESC. Its aim is to improve the quality of life of the European population by reducing the impact of cardiac arrhythmias and reduce sudden cardiac death.About the ESCThe European Society of Cardiology (ESC) represents more than 80,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.